查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1832505

白内障手术设备市场：按产品类型、技术和最终用户 - 全球预测 2025-2032

Cataract Surgery Devices Market by Product Type, Technology, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，白内障手术设备市场将成长至 149.3 亿美元，复合年增长率为 8.30%。

主要市场统计数据
基准年2024年 78.8亿美元
预计2025年 85.3亿美元
预测年份：2032年 149.3亿美元
复合年增长率（%） 8.30%

从临床创新、不断变化的医疗环境和采购需求的角度来看待不断发展的白内障手术设备市场

白内障手术器材在外科创新、人口需求和不断发展的医疗保健服务的交汇处占据关键地位。在过去十年中，该领域已从依赖传统的乳化和单焦点晶状体发展到更多样化的选择，旨在改善屈光效果、缩短恢復时间并扩大手术的安全环境。这些进步得益于影像处理、雷射精度、人工水晶体设计以及旨在保护眼组织和优化术中操作的耗材的同步进步。

因此，临床团队、采购主管和设备製造商面临着一个这样的情况：互通性、可预测的供应链以及与临床结果紧密相关的清晰价值命题将获得回报。随着治疗途径从中心医院转向门诊手术中心和专科眼科诊所，设备的选择越来越多地反映手术量、与现有平台的兼容性以及对新兴屈光技术的支持。在此背景下，仔细综合设备效能、监管趋势和最终用户偏好对于制定采购策略、临床应用和产品开发蓝图至关重要。

精密雷射、多样化的人工水晶体结构以及分散的医疗保健服务如何重新定义临床实践和供应商策略

白内障手术设备领域正在经历数次变革，这些变革正在再形成临床通讯协定、供应商策略和投资重点。首先，精准引导的飞秒雷射系统正在改变手动操作的作用，使其能够实现更可重复的囊膜切口和精准的弧形切口，从而影响高端人工水晶体的选择和屈光结果的预期。同时，人工水晶体的设计也正在从单焦光学元件向扩展景深、多焦、散光和高度非球面镜片等多样化发展，从而扩大了患者群体，并促进了围绕高端护理的报销谈判。

同时，白内障治疗正转向门诊手术中心和高容量眼科诊所，在这些地方，吞吐量和设备相容性与设备性能同等重要。这种分散化趋势促使设备製造商优先考虑模组化系统、精简的耗材物流以及旨在降低手术结果差异性的培训方案。最后，数位化整合正在成为一项差异化因素，涵盖从手术全期影像到手术规划软体，再到与电子健康记录的互通性。总而言之，这些转变有利于那些能够展现卓越临床表现、经济清晰性以及无缝融入不同护理途径能力的供应商。

检验2025 年美国关税对营运和采购的影响，以及对设备采购和临床采用的影响

近期的关税行动以及美国2025年更广泛的贸易政策环境，对整个白内障手术供应链产生了重大波动，促使製造商和医疗保健提供者重新评估筹资策略和成本结构。由于许多医疗设备和关键零件在多个地区生产，进口关税的提高引发了各种应对措施。一些供应商暂时吸收成本以维持市场进入，另一些供应商则将采购转向国内或享受关税豁免的供应商，还有一些供应商加快了关键组件的本地化进程。因此，采购计划和供应商谈判现在纳入了更清晰的紧急条款和近期风险评估。

除了直接的成本影响外，关税还透过改变高端人工水晶体、飞秒雷射模组和高端乳化主机的相对定价，影响了临床应用途径。寻求可预测预算的医疗保健系统高度重视多年期服务合约和捆绑定价，而门诊中心则强调每个总成本和耗材的可用性。重要的是，监管协调和加快清关流程成为营运槓桿。拥有强大合规文件、本地仓储和快速更换能力的製造商获得了竞争优势。除非贸易政策稳定下来，否则这种动态可能会持续下去，这凸显了筹资策略中建立多元化供应商关係和透明定价模式的必要性。

详细的细分洞察，展示产品类型、技术工作流程和护理环境如何推动采用模式、培训需求和采购优先级

关键细分洞察揭示了产品设计、手术技术和最终用户偏好如何影响白内障手术器械的采用模式和投资重点。首先，检视产品类型可以发现，产品类型涵盖了从飞秒雷射系统等资本密集平台到耗材和超音波乳化机主机等一系列产品。人工水晶体在这一频谱占据核心地位，并进一步细分为用于优化影像品质的非球面设计、用于增强功能性视野的扩展景深镜片、实用的预设单光镜片、用于不戴眼镜的多焦点解决方案以及用于矫正散光的散光镜片。每个子类别都有不同的临床训练要求，并影响术后患者满意度指标。

从技术层面来看，囊外白内障摘除术与飞秒雷射辅助手术、小切口技术和乳化/抽吸等更先进的手术方法之间存在明显差异。在飞秒辅助工作流程中，用于散光管理的弓形切口、用于稳定晶状体聚焦的囊切开术以及用于降低晶状体能量的晶状体碎裂术等手术模组推动着互补设备采购和手术标准化。门诊手术中心和眼科诊所通常优先考虑吞吐量、设备占地面积和耗材物流，而眼科研究机构则强调研究级的多功能性和临床试验准备度，医院则重视服务的广度和跨专业整合。这些细分轴线相互契合，表明成功的商业策略必须将产品模组化、培训支援和服务模式与每个临床环境独特的营运现实相结合。

美洲、欧洲、中东和非洲以及亚太地区的报销模式、手术量和基础设施的差异如何影响设备策略

在全球白内障生态系统中，区域动态仍然是决定设备销售策略和商业化方法的关键因素。在美洲，强大的私人支付方参与度加上广泛的门诊手术中心网络，催生了对能够提供高效吞吐、可预测结果和强大售后服务的设备的需求。相反，美洲的机构投资者通常需要整合的平台相容性和清晰的临床经济效益来支持资本投资决策。放眼欧洲、中东和非洲，该地区的法规环境和报销模式各不相同，高端晶体和雷射平台在欧洲部分地区迅速普及，而其他市场则优先考虑成本效益和公共采购管道。在这些地区，集中采购机制和国家临床指南对设备采用时间表有显着影响。

亚太地区是一个复杂的地区，既有大型白内障项目，也有快速现代化的私人医疗保健行业，而且该地区的医疗负担能力仍然是主要限制因素。在亚太地区的多个市场，高手术量加上不断增长的中阶需求，正在刺激对扩充性超音波乳化系统和高端人工水晶体的投资，但供应商必须根据当地的报销情况调整其服务模式和耗材定价。所有地区的通用包括培训生态系统、供应链弹性和监管敏捷性日益重要。能够调整区域市场策略以平衡成本、预期结果和基础设施能力的製造商将占据有利地位，并抓住多样化的成长机会。

平台现有企业、镜片创新者和软体颠覆者之间的竞争动态和策略行动塑造了临床应用和商业性优势

白内障手术设备领域的公司层面动态呈现以下特点：成熟的平台提供者、专业人工水晶体创新者，以及专注于软体驱动的手术计划和耗材优化的灵活新参与企业。一直以来提供全平台解决方案的现有企业正在利用装置量，提升销售模组化升级、服务合约和培训套餐，以深化临床关係并确保持续的收益来源。同时，专业人工水晶体的开发人员正透过光学工程、先进材料科学和临床证据，证明其为目标患者群体提供明显的屈光优势，脱颖而出。

新参与企业和医疗技术扩张企业正在透过引入可互通的规划软体、屈光结果的数位分析以及降低单例成本的供应链创新，挑战传统的界限。策略伙伴关係和分销协议仍然是加速市场进入的首选途径，尤其对于那些希望进入高度监管市场或扩展医院网路的公司。此外，投资强大的临床教育计画和结果登记的组织往往能够建立更强大的临床医生支持，并加速新技术的采用。最终，竞争优势在于那些将产品创新与可证明的临床效益、灵活的商业模式和可靠的售后支援相结合的公司。

加速技术采用、确保采购优势、加强供应链和临床支援能力的实用策略

对于寻求将情报转化为影响力的行业领导者，一系列切实可行的建议可以加速临床应用，增强供应链韧性，并优化商业性定位。首先，透过优先考虑能够减少术中变异性、改善患者报告结果并融入现有手术工作流程的功能，使产品开发与检验的临床需求保持一致。这样做将使製造商能够向外科医生和采购委员会阐明其价值提案。其次，发展弹性价格设定和服务模式，以应对门诊手术中心、医院和专科诊所不同的经济状况，并认识到每例病例的总成本和耗材物流通常会影响采购决策。

此外，多元化供应商网路并在高需求地区建立在局部库存缓衝可以降低贸易和监管风险。投资于临床医生教育和全面的结果追踪可带来双重益处。最后，透过开放的手术计画和文件标准追求互通性，可以提高与医院IT系统的兼容性，并降低采用门槛。这些措施共同构成了切实可行的蓝图，旨在提高市场接受度，同时减少医疗服务提供者和製造商的营运摩擦。

将主要临床医生和采购负责人的参与与二次证据综合和严格的交叉检验程序相结合的调查方法框架

本报告背后的调查方法将系统性的一手资料研究与二手证据的综合整合相结合，以确保获得可靠且可操作的见解。主要方法包括对执业眼科医师、医院和门诊中心的采购负责人以及负责平台整合的设备工程师进行结构化访谈。此外，我们也参观了手术量较大的手术中心，并咨询了监管专家，以确认设备是否符合批准和上市后要求。这些资讯来源的数据与同行评审文献、临床结果登记和设备标籤进行了交叉引用，以检验技术声明和性能差距。

分析方法包括对临床医生优先事项的定性主题分析、供应商能力映射以及情境评估，以探索贸易政策变化和报销变化的敏感性。品质保证步骤包括对访谈结果进行交叉检验、与临床顾问共同审查调查方法，以及根据相关人员的回馈反覆完善假设。这些方法的结合提供了一个平衡的视角，整合了临床判断、营运现状和监管环境，为读者提供采购、产品开发和上市策略的实际指导。

整合临床创新、营运适应性和供应链弹性，确保白内障护理的永续采用和竞争地位

最后，白内障手术设备正处于曲折点，技术创新、医疗服务分散化以及地缘政治因素共同影响临床实务和商业策略。高精度雷射、先进的人工水晶体光学系统和数位化手术规划正在扩大可实现的患者治疗效果，而向门诊治疗的转变则提升了吞吐量、设备相容性和耗材物流的重要性。同时，贸易政策的发展凸显了全球供应链的脆弱性，并凸显了本地製造和弹性采购的战略价值。

因此，投资于循证产品差异化、强大的临床医生教育和富有韧性的供应生态系统的相关人员，将更有能力应对不确定性并抓住机会。透过将临床优先事项与营运限制和监管环境结合，决策者可以製定策略，推动持续应用，改善患者治疗效果，并在快速发展的市场环境中增强竞争地位。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 越来越多地采用人工智慧驱动的生物识别分析系统来个性化选择人工水晶体度数
  • 飞秒雷射辅助白内障手术与光学同调断层扫描导引的快速发展
  • 开发并商业化可有效矫正老花眼并扩大景深、改善视力的人工水晶体。
  • 新兴医疗保健市场的扩大推动了对可携式超音波和手持式手术设备的需求
  • 引进远距眼科平台和远端监控技术进行白内障术后患者管理

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章白内障手术设备市场（依产品类型）

  • 飞秒雷射系统
  • 人工水晶体
    • 非人工水晶体
    • 扩大景深的人工水晶体
    • 单焦点人工水晶体
    • 多焦点人工水晶体
    • 人工水晶体
  • 眼部黏弹性装置
  • 超音波乳化装置
  • 手术耗材

第九章 白内障手术设备市场：依技术

  • 白内障囊外摘除术
  • 飞秒雷射辅助
    • 弓形切口
    • 囊切开术
    • 晶状体碎裂
  • 手动小切口
  • 超音波

第 10 章白内障手术设备市场（依最终使用者）

  • 门诊手术中心
  • 眼科研究所
  • 医院
  • 眼科诊所

第 11 章白内障手术设备市场：按地区

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章 白内障手术设备市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章 白内障手术设备市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Alcon, Inc.
    • Johnson & Johnson Vision Care, Inc.
    • Bausch & Lomb Incorporated
    • HOYA Surgical Optics, Inc.
    • Carl Zeiss Meditec AG
    • STAAR Surgical Company
    • NIDEK Co., Ltd.
    • Rayner Intraocular Lenses Limited
    • PhysIOL SA
    • Lenstec, Inc.
Product Code: MRR-433AB1DC28B7

The Cataract Surgery Devices Market is projected to grow by USD 14.93 billion at a CAGR of 8.30% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.88 billion
Estimated Year [2025] USD 8.53 billion
Forecast Year [2032] USD 14.93 billion
CAGR (%) 8.30%

Framing the evolving cataract surgery device landscape in the context of clinical innovation, care setting shifts, and procurement imperatives

Cataract surgery devices occupy a pivotal position at the intersection of surgical innovation, demographic need, and healthcare delivery evolution. Over the past decade the field has advanced from reliance on conventional phacoemulsification and monofocal lenses toward a more diverse set of options that aim to improve refractive outcomes, reduce recovery times, and expand the settings in which procedures can be safely performed. These advances have been driven by parallel progress in imaging, laser precision, intraocular lens design, and consumables engineered to preserve ocular tissue and optimize intraoperative handling.

Consequently, clinical teams, procurement leaders, and device manufacturers are confronting a landscape that rewards interoperability, predictable supply chains, and a clear value proposition tied to clinical outcomes. As care pathways migrate from centralized hospitals to ambulatory surgery centers and specialty eye clinics, device selection increasingly reflects procedural throughput, compatibility with existing platforms, and support for emerging refractive technologies. In this context, a careful synthesis of device capabilities, regulatory trajectories, and end-user preferences is essential to inform purchasing strategies, clinical adoption, and product development roadmaps.

How precision lasers, diversified intraocular lens architectures, and care delivery decentralization are redefining clinical practice and supplier strategy

The cataract surgery device landscape is undergoing several transformative shifts that are reshaping clinical protocols, vendor strategies, and investment priorities. First, precision-guided femtosecond laser systems are altering the role of manual maneuvers by enabling more reproducible capsulotomies and targeted arcuate incisions, which in turn influence the selection of premium intraocular lenses and the expectation of refractive outcomes. In parallel, intraocular lens design has diversified beyond monofocal optics to include extended depth of focus, multifocal, toric, and advanced aspheric profiles, thereby broadening the patient populations and reimbursement conversations around premium care.

Simultaneously, the operational footprint of cataract care is shifting toward ambulatory surgery centers and high-volume ophthalmology clinics where throughput and device compatibility matter as much as instrument performance. This decentralization encourages device makers to prioritize modular systems, streamlined consumable logistics, and training packages that reduce variability in surgical results. Finally, digital integration-ranging from perioperative imaging to surgical planning software and interoperability with electronic health records-is emerging as a differentiator. Taken together, these shifts favor suppliers who can demonstrate clinical advantage, economic clarity, and an ability to integrate seamlessly into diverse care pathways.

Examining the operational and procurement consequences of U.S. tariff measures in 2025 and their implications for device sourcing and clinical adoption

Recent tariff actions and the broader trade policy environment in the United States in 2025 have created material reverberations across supply chains for cataract surgery devices, prompting manufacturers and providers to reassess sourcing strategies and cost structures. Because many devices and key components are manufactured across multiple geographies, incremental import levies have initiated a cascade of responses: some suppliers absorbed costs temporarily to preserve market access, others shifted procurement toward domestic or tariff-exempt suppliers, and a subset accelerated localization of critical subassemblies. As a result, purchasing timelines and vendor negotiations incorporated more explicit contingency clauses and near-term risk assessments.

Beyond direct cost implications, tariffs have influenced clinical adoption pathways by altering the relative price of premium intraocular lenses, femtosecond laser modules, and high-end phacoemulsification consoles. Healthcare systems pursuing predictable budgeting placed higher value on multi-year service agreements and bundled pricing, while ambulatory centers emphasized total cost per case and consumable availability. Importantly, regulatory alignment and expedited customs processes emerged as operational levers; manufacturers that demonstrated robust compliance documentation, local warehousing, and rapid replacement capability gained competitive advantage. Looking forward, these dynamics are likely to persist unless trade policies stabilize, underscoring the need for diversified supplier relationships and transparent price modeling within procurement strategies.

Detailed segmentation insights showing how product types, technology workflows, and care settings determine adoption patterns, training needs, and procurement priorities

Critical segmentation insights reveal how product design, procedural technology, and end-user setting jointly shape adoption patterns and investment priorities in cataract surgery devices. First, examining product type shows a continuum from high-capital platforms like femtosecond laser systems to consumables and phaco consoles. Intraocular lenses occupy a central role within this spectrum and further differentiate into aspheric designs aimed at image quality optimization, extended depth of focus lenses that broaden functional vision, monofocal lenses that remain the pragmatic default, multifocal solutions intended for spectacle independence, and toric lenses that address astigmatism correction. Each subcategory imposes distinct clinical training requirements and influences postoperative patient satisfaction metrics.

Turning to technology-based segmentation, there is a clear divide between extracapsular cataract extraction methods and more contemporary approaches such as femtosecond laser assisted surgery, manual small incision techniques, and phacoemulsification. Within femtosecond-assisted workflows, procedural modules like arcuate incisions for astigmatism management, capsulotomy for consistent lens centration, and lens fragmentation for reduced phaco energy are driving complementary device purchases and procedural standardization. Finally, end-user segmentation demonstrates differentiated purchasing priorities: ambulatory surgery centers and ophthalmology clinics often prioritize throughput, instrument footprint, and consumable logistics; eye institutes focus on research-grade versatility and clinical trial readiness; hospitals emphasize breadth of service and cross-specialty integration. Together, these segmentation axes indicate that successful commercial strategies must align product modularity, training support, and service models with the unique operational realities of each care setting.

How regional reimbursement models, surgical volumes, and infrastructure differences across the Americas, Europe Middle East & Africa, and Asia-Pacific shape device strategies

Regional dynamics remain a primary determinant of device distribution strategies and commercialization approaches across the global cataract ecosystem. In the Americas, strong private payer participation combined with an extensive network of ambulatory surgery centers creates demand for devices that deliver throughput efficiency, predictable outcomes, and strong post-sale service. Conversely, institutional purchasing in the Americas often demands integrated platform compatibility and clear clinical-economic rationale to support capital investment decisions. Moving to Europe, Middle East & Africa, the region exhibits heterogenous regulatory environments and reimbursement models, with parts of Europe demonstrating rapid uptake of premium lenses and laser platforms while other markets prioritize cost-effectiveness and public procurement channels. In these territories, centralized procurement mechanisms and national clinical guidelines significantly influence adoption timelines.

Asia-Pacific presents a complex mix of high-volume cataract programs, rapidly modernizing private healthcare sectors, and regions where affordability remains the primary constraint. In several Asia-Pacific markets, the combination of high surgical volume and growing middle-class demand is spurring investment in both scalable phaco systems and premium IOL options, but suppliers must tailor service models and consumable pricing to local reimbursement realities. Across all regions, common threads include the rising importance of training ecosystems, supply chain resilience, and regulatory agility. Manufacturers that adapt regional go-to-market strategies to the local balance between cost, outcome expectations, and infrastructure capacity will be better positioned to capture diverse growth opportunities.

Competitive dynamics and strategic behaviors among platform incumbents, lens innovators, and software disruptors shaping clinical adoption and commercial advantage

Company-level dynamics in the cataract devices space are characterized by a combination of incumbent platform providers, specialized lens innovators, and agile newcomers focused on software-enabled surgical planning and consumables optimization. Incumbents that have historically delivered full-platform solutions are leveraging installed bases to upsell modular upgrades, service agreements, and training packages, thereby deepening clinical relationships and securing recurring revenue streams. At the same time, specialized intraocular lens developers are differentiating through optical engineering, premium material science, and clinical evidence that demonstrates distinct refractive advantages for targeted patient cohorts.

Newer entrants and medtech scale-ups are challenging traditional boundaries by introducing interoperable planning software, digital analytics for refractive outcomes, and supply chain innovations that reduce per-case costs. Strategic partnerships and distribution agreements remain preferred routes to accelerate market access, particularly for companies seeking to enter highly regulated markets or to expand hospital networks. Moreover, organizations that invest in robust clinical education programs and outcome registries tend to build stronger clinician advocacy and faster uptake of newer technologies. Ultimately, competitive advantage accrues to companies that align product innovation with demonstrable clinical benefit, flexible commercial models, and proven post-sale support.

Practical strategic recommendations to accelerate technology adoption, secure procurement advantage, and enhance supply chain and clinical support capabilities

For industry leaders seeking to translate intelligence into impact, a set of actionable recommendations can expedite clinical adoption, strengthen supply chain resilience, and optimize commercial positioning. First, align product development with validated clinical needs by prioritizing features that reduce intraoperative variability, improve patient-reported outcomes, and integrate into existing surgical workflows. By doing so, manufacturers will make the value proposition clearer to both surgeons and procurement committees. Second, develop flexible pricing and service models that accommodate the distinct economics of ambulatory surgery centers, hospitals, and specialty clinics, recognizing that total cost per case and consumable logistics are frequently decisive in purchase decisions.

Additionally, mitigate trade and regulatory risk by diversifying supplier networks and establishing localized inventory buffers in high-demand regions. Investing in clinician education and comprehensive outcome tracking provides a dual benefit: it accelerates evidence generation needed for premium device adoption and strengthens post-market surveillance. Finally, pursue interoperability through open standards for surgical planning and documentation, which will enhance compatibility with hospital IT systems and reduce barriers to adoption. Taken together, these steps create a practical roadmap for improving market receptivity while reducing operational friction for both providers and manufacturers.

Methodological framework combining primary clinician and procurement engagement with secondary evidence synthesis and rigorous cross-validation procedures

The research methodology underpinning this report combines systematic primary engagement with secondary evidence synthesis to ensure robust, actionable insights. Primary methods included structured interviews with practicing ophthalmic surgeons, procurement leaders across hospitals and ambulatory centers, and device engineers responsible for platform integration. These engagements were complemented by site visits to high-volume surgical centers and consultations with regulatory specialists to verify device clearances and post-market requirements. Data from these sources were triangulated with peer-reviewed literature, clinical outcome registries, and device labeling to validate technical claims and performance differentials.

Analytical approaches encompassed qualitative thematic analysis of clinician priorities, supplier capability mapping, and scenario assessments to explore sensitivity to trade policy shifts and reimbursement changes. Quality assurance steps included cross-validation of interview findings, review of methodology by clinical advisors, and iterative refinement of assumptions through stakeholder feedback. Together, these methods produced a balanced view that integrates clinical judgment, operational realities, and regulatory context, enabling readers to derive practical implications for procurement, product development, and market entry strategies.

Integrating clinical innovation, operational adaptability, and supply chain resilience to secure sustainable adoption and competitive positioning in cataract therapy

In closing, cataract surgery devices are at an inflection point where technological innovation, care delivery decentralization, and geopolitical factors collectively influence clinical practice and commercial strategy. Precision lasers, advanced intraocular lens optics, and digital surgical planning are expanding the set of achievable patient outcomes, while shifts toward ambulatory settings elevate the importance of throughput, device compatibility, and consumable logistics. Concurrently, trade policy developments have underscored the vulnerability of global supply chains and the strategic value of localized manufacturing and flexible procurement arrangements.

Therefore, stakeholders who invest in evidence-based product differentiation, robust clinician education, and resilient supply ecosystems will be better equipped to navigate uncertainty and capitalize on opportunities. By synthesizing clinical priorities with operational constraints and regulatory considerations, decision-makers can craft strategies that promote sustainable adoption, improve patient outcomes, and strengthen competitive positioning in a rapidly evolving landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. The increasing adoption of artificial intelligence-driven biometric analysis systems for personalized intraocular lens power selection
  • 5.2. Rapid growth of femtosecond laser-assisted cataract surgery integrated with optical coherence tomography guidance
  • 5.3. Development and commercialization of advanced presbyopia-correcting and extended depth of focus intraocular lenses with improved visual outcomes
  • 5.4. Rising demand for portable phacoemulsification units and hand-held surgical devices to expand access in emerging healthcare markets
  • 5.5. Implementation of teleophthalmology platforms and remote monitoring technologies for postoperative cataract surgery patient management

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cataract Surgery Devices Market, by Product Type

  • 8.1. Femtosecond Laser Systems
  • 8.2. Intraocular Lenses
    • 8.2.1. Aspheric Iols
    • 8.2.2. Extended Depth Of Focus Iols
    • 8.2.3. Monofocal Iols
    • 8.2.4. Multifocal Iols
    • 8.2.5. Toric Iols
  • 8.3. Ocular Viscoelastic Devices
  • 8.4. Phacoemulsification Equipment
  • 8.5. Surgical Consumables

9. Cataract Surgery Devices Market, by Technology

  • 9.1. Extracapsular Cataract Extraction
  • 9.2. Femtosecond Laser Assisted
    • 9.2.1. Arcuate Incisions
    • 9.2.2. Capsulotomy
    • 9.2.3. Lens Fragmentation
  • 9.3. Manual Small Incision
  • 9.4. Phacoemulsification

10. Cataract Surgery Devices Market, by End User

  • 10.1. Ambulatory Surgery Centers
  • 10.2. Eye Institutes
  • 10.3. Hospitals
  • 10.4. Ophthalmology Clinics

11. Cataract Surgery Devices Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Cataract Surgery Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Cataract Surgery Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Alcon, Inc.
    • 14.3.2. Johnson & Johnson Vision Care, Inc.
    • 14.3.3. Bausch & Lomb Incorporated
    • 14.3.4. HOYA Surgical Optics, Inc.
    • 14.3.5. Carl Zeiss Meditec AG
    • 14.3.6. STAAR Surgical Company
    • 14.3.7. NIDEK Co., Ltd.
    • 14.3.8. Rayner Intraocular Lenses Limited
    • 14.3.9. PhysIOL SA
    • 14.3.10. Lenstec, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. CATARACT SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. CATARACT SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CATARACT SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 246. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 251. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 258. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 259. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 262. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 263. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 282. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 283. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 285. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 286. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 287. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 294. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 295. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 296. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 297. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 298. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 299. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 306. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 307. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 308. NATO CATARACT SURGERY D